aluates Reports

$ 0.0

Automative

Global Nocturia Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-15D6207

Global Nocturia Market Insights and Forecast to 2028

BUY CHAPTERS

Global Nocturia Market Research Report 2025

Code: QYRE-Auto-15D6207

Report

March 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergan plc

Ferring Pharmaceuticals

Astellas Pharma

Eli Lilly

GlaxoSmithKline PLC

Sanofi

Pfizer Inc

Abbott

TEVA

Mylan NV

Johnson & Johnson

Hainan Zhonghe Pharmaceutical

Novartis

Merck

Astra Zeneca

Bristol–Myers Squibb

Fosun Pharma

Hybio Pharmaceutical

Rechon Life Science AB

Zhejiang Conba Pharmaceutical

Chengdu Leer Pharmaceutical

Sun Pharmaceutical Industries Ltd.

Apotex

Sagent Pharmaceuticals

Nanjing Xingyin Pharmaceutical Group

Nocturia Market Size

The global market for Nocturia was valued at US$ 2849 million in the year 2024 and is projected to reach a revised size of US$ 4204 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Nocturia Market

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.

The global nocturia market, focused on the treatment of nighttime urination, is growing due to an increasing aging population, rising awareness of urinary disorders, and advancements in treatment options. Below are some key trends driving the market:

1. Growing Aging Population

Primary Driver: Nocturia is more prevalent among the elderly, and with a rapidly aging global population, the demand for nocturia treatments is rising. Regions with older populations, such as Europe, North America, and Japan, are seeing increased incidence rates.

Impact: The increase in elderly individuals with nocturia-related issues is expected to drive the demand for pharmaceutical treatments and non-pharmaceutical interventions.

2. Advancements in Treatment Options

Medications: A range of medications, including anticholinergics, desmopressin, and beta-3 adrenergic receptor agonists, are commonly used to treat nocturia. New drug formulations are being developed to reduce side effects and improve efficacy.

Emerging Therapies: Research into gene therapies and targeted molecular therapies is advancing. Additionally, the combination of medications for better symptom control is being explored.

Non-Pharmacological Treatments: Beyond drugs, lifestyle interventions, such as fluid management, bladder training, and devices like bedwetting alarms, are gaining attention as complementary treatments.

3. Increasing Awareness and Diagnosis

Education: Public health campaigns and awareness programs about nocturia are encouraging individuals to seek medical help. Increased awareness is expected to drive the market as more people seek treatment for the condition.

Early Diagnosis: Enhanced diagnostic tools, including better urodynamic testing and digital health platforms for symptom tracking, are improving early detection and management of nocturia.

4. Regional Growth

North America: The U.S. holds the largest market share due to its advanced healthcare infrastructure, higher awareness, and the presence of major pharmaceutical companies. Increasing cases of nocturia among older adults are a significant market driver.

Europe: Aging populations, particularly in Western Europe, are contributing to the increased demand for nocturia treatments. The market in this region benefits from well-established healthcare systems.

Asia-Pacific: The growing healthcare infrastructure in countries like China, Japan, and India is expected to boost market growth. Rising healthcare expenditure and increasing elderly populations in these regions are key factors.

Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.

The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by Type, by Sale Channels, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channels, and by regions.

Market Segmentation

Scope of Nocturia Market Report

Report Metric	Details
Report Name	Nocturia Market
Accounted market size in year	US$ 2849 million
Forecasted market size in 2031	US$ 4204 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Desmopressin Anticholinergic Drugs Alpha Blockers Diuretics Others
Segment by Sale Channels	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, Novartis, Johnson & Johnson, Merck, Astra Zeneca, Bristol-Myers Squibb, Hainan Zhonghe Pharmaceutical, Fosun Pharma, Hybio Pharmaceutical, Rechon Life Science AB, Zhejiang Conba Pharmaceutical, Chengdu Leer Pharmaceutical, Nanjing Xingyin Pharmaceutical Group, Sun Pharmaceutical Industries Ltd., APOTEX INC, Sagent Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sale Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nocturia company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nocturia Market growing?

Ans: The Nocturia Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Nocturia Market size in 2031?

Ans: The Nocturia Market size in 2031 will be US$ 4204 million.

What is the market share of major companies in Nocturia Market?

Ans: The top 2 companies hold a share about 30%.

What is the Nocturia Market share by region?

Ans: North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%.

What is the Nocturia Market share by type?

Ans: In terms of product, alpha blockers is the largest segment, with a share over 37%.

Who are the main players in the Nocturia Market report?

Ans: The main players in the Nocturia Market are Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, Novartis, Johnson & Johnson, Merck, Astra Zeneca, Bristol-Myers Squibb, Hainan Zhonghe Pharmaceutical, Fosun Pharma, Hybio Pharmaceutical, Rechon Life Science AB, Zhejiang Conba Pharmaceutical, Chengdu Leer Pharmaceutical, Nanjing Xingyin Pharmaceutical Group, Sun Pharmaceutical Industries Ltd., APOTEX INC, Sagent Pharmaceuticals

What are the Type segmentation covered in the Nocturia Market report?

Ans: The Types covered in the Nocturia Market report are Desmopressin, Anticholinergic Drugs, Alpha Blockers, Diuretics, Others

Recommended Reports

Urinary Disorder Treatments

Sleep Disorder Therapies

Genitourinary Disease Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nocturia Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Desmopressin

1.2.3 Anticholinergic Drugs

1.2.4 Alpha Blockers

1.2.5 Diuretics

1.2.6 Others

1.3 Market by Sale Channels

1.3.1 Global Nocturia Market Growth by Sale Channels: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nocturia Market Perspective (2020-2031)

2.2 Global Nocturia Growth Trends by Region

2.2.1 Global Nocturia Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nocturia Historic Market Size by Region (2020-2025)

2.2.3 Nocturia Forecasted Market Size by Region (2026-2031)

2.3 Nocturia Market Dynamics

2.3.1 Nocturia Industry Trends

2.3.2 Nocturia Market Drivers

2.3.3 Nocturia Market Challenges

2.3.4 Nocturia Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nocturia Players by Revenue

3.1.1 Global Top Nocturia Players by Revenue (2020-2025)

3.1.2 Global Nocturia Revenue Market Share by Players (2020-2025)

3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nocturia Revenue

3.4 Global Nocturia Market Concentration Ratio

3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2024

3.5 Global Key Players of Nocturia Head office and Area Served

3.6 Global Key Players of Nocturia, Product and Application

3.7 Global Key Players of Nocturia, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nocturia Breakdown Data by Type

4.1 Global Nocturia Historic Market Size by Type (2020-2025)

4.2 Global Nocturia Forecasted Market Size by Type (2026-2031)

5 Nocturia Breakdown Data by Sale Channels

5.1 Global Nocturia Historic Market Size by Sale Channels (2020-2025)

5.2 Global Nocturia Forecasted Market Size by Sale Channels (2026-2031)

6 North America

6.1 North America Nocturia Market Size (2020-2031)

6.2 North America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nocturia Market Size by Country (2020-2025)

6.4 North America Nocturia Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nocturia Market Size (2020-2031)

7.2 Europe Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nocturia Market Size by Country (2020-2025)

7.4 Europe Nocturia Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nocturia Market Size (2020-2031)

8.2 Asia-Pacific Nocturia Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nocturia Market Size by Region (2020-2025)

8.4 Asia-Pacific Nocturia Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nocturia Market Size (2020-2031)

9.2 Latin America Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nocturia Market Size by Country (2020-2025)

9.4 Latin America Nocturia Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nocturia Market Size (2020-2031)

10.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nocturia Market Size by Country (2020-2025)

10.4 Middle East & Africa Nocturia Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Astellas Pharma

11.1.1 Astellas Pharma Company Details

11.1.2 Astellas Pharma Business Overview

11.1.3 Astellas Pharma Nocturia Introduction

11.1.4 Astellas Pharma Revenue in Nocturia Business (2020-2025)

11.1.5 Astellas Pharma Recent Development

11.2 Allergan

11.2.1 Allergan Company Details

11.2.2 Allergan Business Overview

11.2.3 Allergan Nocturia Introduction

11.2.4 Allergan Revenue in Nocturia Business (2020-2025)

11.2.5 Allergan Recent Development

11.3 Ferring Pharmaceuticals

11.3.1 Ferring Pharmaceuticals Company Details

11.3.2 Ferring Pharmaceuticals Business Overview

11.3.3 Ferring Pharmaceuticals Nocturia Introduction

11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025)

11.3.5 Ferring Pharmaceuticals Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Nocturia Introduction

11.4.4 Eli Lilly Revenue in Nocturia Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Details

11.5.2 GlaxoSmithKline Business Overview

11.5.3 GlaxoSmithKline Nocturia Introduction

11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2020-2025)

11.5.5 GlaxoSmithKline Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Details

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Nocturia Introduction

11.6.4 Sanofi Revenue in Nocturia Business (2020-2025)

11.6.5 Sanofi Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Nocturia Introduction

11.7.4 Pfizer Revenue in Nocturia Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Abbott

11.8.1 Abbott Company Details

11.8.2 Abbott Business Overview

11.8.3 Abbott Nocturia Introduction

11.8.4 Abbott Revenue in Nocturia Business (2020-2025)

11.8.5 Abbott Recent Development

11.9 Teva

11.9.1 Teva Company Details

11.9.2 Teva Business Overview

11.9.3 Teva Nocturia Introduction

11.9.4 Teva Revenue in Nocturia Business (2020-2025)

11.9.5 Teva Recent Development

11.10 Mylan

11.10.1 Mylan Company Details

11.10.2 Mylan Business Overview

11.10.3 Mylan Nocturia Introduction

11.10.4 Mylan Revenue in Nocturia Business (2020-2025)

11.10.5 Mylan Recent Development

11.11 Novartis

11.11.1 Novartis Company Details

11.11.2 Novartis Business Overview

11.11.3 Novartis Nocturia Introduction

11.11.4 Novartis Revenue in Nocturia Business (2020-2025)

11.11.5 Novartis Recent Development

11.12 Johnson & Johnson

11.12.1 Johnson & Johnson Company Details

11.12.2 Johnson & Johnson Business Overview

11.12.3 Johnson & Johnson Nocturia Introduction

11.12.4 Johnson & Johnson Revenue in Nocturia Business (2020-2025)

11.12.5 Johnson & Johnson Recent Development

11.13 Merck

11.13.1 Merck Company Details

11.13.2 Merck Business Overview

11.13.3 Merck Nocturia Introduction

11.13.4 Merck Revenue in Nocturia Business (2020-2025)

11.13.5 Merck Recent Development

11.14 Astra Zeneca

11.14.1 Astra Zeneca Company Details

11.14.2 Astra Zeneca Business Overview

11.14.3 Astra Zeneca Nocturia Introduction

11.14.4 Astra Zeneca Revenue in Nocturia Business (2020-2025)

11.14.5 Astra Zeneca Recent Development

11.15 Bristol-Myers Squibb

11.15.1 Bristol-Myers Squibb Company Details

11.15.2 Bristol-Myers Squibb Business Overview

11.15.3 Bristol-Myers Squibb Nocturia Introduction

11.15.4 Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025)

11.15.5 Bristol-Myers Squibb Recent Development

11.16 Hainan Zhonghe Pharmaceutical

11.16.1 Hainan Zhonghe Pharmaceutical Company Details

11.16.2 Hainan Zhonghe Pharmaceutical Business Overview

11.16.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction

11.16.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025)

11.16.5 Hainan Zhonghe Pharmaceutical Recent Development

11.17 Fosun Pharma

11.17.1 Fosun Pharma Company Details

11.17.2 Fosun Pharma Business Overview

11.17.3 Fosun Pharma Nocturia Introduction

11.17.4 Fosun Pharma Revenue in Nocturia Business (2020-2025)

11.17.5 Fosun Pharma Recent Development

11.18 Hybio Pharmaceutical

11.18.1 Hybio Pharmaceutical Company Details

11.18.2 Hybio Pharmaceutical Business Overview

11.18.3 Hybio Pharmaceutical Nocturia Introduction

11.18.4 Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025)

11.18.5 Hybio Pharmaceutical Recent Development

11.19 Rechon Life Science AB

11.19.1 Rechon Life Science AB Company Details

11.19.2 Rechon Life Science AB Business Overview

11.19.3 Rechon Life Science AB Nocturia Introduction

11.19.4 Rechon Life Science AB Revenue in Nocturia Business (2020-2025)

11.19.5 Rechon Life Science AB Recent Development

11.20 Zhejiang Conba Pharmaceutical

11.20.1 Zhejiang Conba Pharmaceutical Company Details

11.20.2 Zhejiang Conba Pharmaceutical Business Overview

11.20.3 Zhejiang Conba Pharmaceutical Nocturia Introduction

11.20.4 Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025)

11.20.5 Zhejiang Conba Pharmaceutical Recent Development

11.21 Chengdu Leer Pharmaceutical

11.21.1 Chengdu Leer Pharmaceutical Company Details

11.21.2 Chengdu Leer Pharmaceutical Business Overview

11.21.3 Chengdu Leer Pharmaceutical Nocturia Introduction

11.21.4 Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025)

11.21.5 Chengdu Leer Pharmaceutical Recent Development

11.22 Nanjing Xingyin Pharmaceutical Group

11.22.1 Nanjing Xingyin Pharmaceutical Group Company Details

11.22.2 Nanjing Xingyin Pharmaceutical Group Business Overview

11.22.3 Nanjing Xingyin Pharmaceutical Group Nocturia Introduction

11.22.4 Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025)

11.22.5 Nanjing Xingyin Pharmaceutical Group Recent Development

11.23 Sun Pharmaceutical Industries Ltd.

11.23.1 Sun Pharmaceutical Industries Ltd. Company Details

11.23.2 Sun Pharmaceutical Industries Ltd. Business Overview

11.23.3 Sun Pharmaceutical Industries Ltd. Nocturia Introduction

11.23.4 Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025)

11.23.5 Sun Pharmaceutical Industries Ltd. Recent Development

11.24 APOTEX INC

11.24.1 APOTEX INC Company Details

11.24.2 APOTEX INC Business Overview

11.24.3 APOTEX INC Nocturia Introduction

11.24.4 APOTEX INC Revenue in Nocturia Business (2020-2025)

11.24.5 APOTEX INC Recent Development

11.25 Sagent Pharmaceuticals

11.25.1 Sagent Pharmaceuticals Company Details

11.25.2 Sagent Pharmaceuticals Business Overview

11.25.3 Sagent Pharmaceuticals Nocturia Introduction

11.25.4 Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025)

11.25.5 Sagent Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Allergan plc

Ferring Pharmaceuticals

Astellas Pharma

Eli Lilly

GlaxoSmithKline PLC

Sanofi

Pfizer Inc

Abbott

TEVA

Mylan NV

Johnson & Johnson

Hainan Zhonghe Pharmaceutical

Novartis

Merck

Astra Zeneca

Bristol–Myers Squibb

Fosun Pharma

Hybio Pharmaceutical

Rechon Life Science AB

Zhejiang Conba Pharmaceutical

Chengdu Leer Pharmaceutical

Sun Pharmaceutical Industries Ltd.

Apotex

Sagent Pharmaceuticals

Nanjing Xingyin Pharmaceutical Group

List of Tables

Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Desmopressin

Table 3. Key Players of Anticholinergic Drugs

Table 4. Key Players of Alpha Blockers

Table 5. Key Players of Diuretics

Table 6. Key Players of Others

Table 7. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Nocturia Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Nocturia Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Nocturia Market Share by Region (2020-2025)

Table 11. Global Nocturia Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Nocturia Market Share by Region (2026-2031)

Table 13. Nocturia Market Trends

Table 14. Nocturia Market Drivers

Table 15. Nocturia Market Challenges

Table 16. Nocturia Market Restraints

Table 17. Global Nocturia Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Nocturia Market Share by Players (2020-2025)

Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2024)

Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Nocturia, Headquarters and Area Served

Table 23. Global Key Players of Nocturia, Product and Application

Table 24. Global Key Players of Nocturia, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Nocturia Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Nocturia Revenue Market Share by Type (2020-2025)

Table 28. Global Nocturia Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Nocturia Revenue Market Share by Type (2026-2031)

Table 30. Global Nocturia Market Size by Sale Channels (2020-2025) & (US$ Million)

Table 31. Global Nocturia Revenue Market Share by Sale Channels (2020-2025)

Table 32. Global Nocturia Forecasted Market Size by Sale Channels (2026-2031) & (US$ Million)

Table 33. Global Nocturia Revenue Market Share by Sale Channels (2026-2031)

Table 34. North America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Nocturia Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Nocturia Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Nocturia Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Nocturia Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Nocturia Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Nocturia Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Nocturia Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Nocturia Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Nocturia Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Nocturia Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Nocturia Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Nocturia Market Size by Country (2026-2031) & (US$ Million)

Table 49. Astellas Pharma Company Details

Table 50. Astellas Pharma Business Overview

Table 51. Astellas Pharma Nocturia Product

Table 52. Astellas Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 53. Astellas Pharma Recent Development

Table 54. Allergan Company Details

Table 55. Allergan Business Overview

Table 56. Allergan Nocturia Product

Table 57. Allergan Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 58. Allergan Recent Development

Table 59. Ferring Pharmaceuticals Company Details

Table 60. Ferring Pharmaceuticals Business Overview

Table 61. Ferring Pharmaceuticals Nocturia Product

Table 62. Ferring Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 63. Ferring Pharmaceuticals Recent Development

Table 64. Eli Lilly Company Details

Table 65. Eli Lilly Business Overview

Table 66. Eli Lilly Nocturia Product

Table 67. Eli Lilly Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 68. Eli Lilly Recent Development

Table 69. GlaxoSmithKline Company Details

Table 70. GlaxoSmithKline Business Overview

Table 71. GlaxoSmithKline Nocturia Product

Table 72. GlaxoSmithKline Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 73. GlaxoSmithKline Recent Development

Table 74. Sanofi Company Details

Table 75. Sanofi Business Overview

Table 76. Sanofi Nocturia Product

Table 77. Sanofi Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 78. Sanofi Recent Development

Table 79. Pfizer Company Details

Table 80. Pfizer Business Overview

Table 81. Pfizer Nocturia Product

Table 82. Pfizer Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 83. Pfizer Recent Development

Table 84. Abbott Company Details

Table 85. Abbott Business Overview

Table 86. Abbott Nocturia Product

Table 87. Abbott Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 88. Abbott Recent Development

Table 89. Teva Company Details

Table 90. Teva Business Overview

Table 91. Teva Nocturia Product

Table 92. Teva Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 93. Teva Recent Development

Table 94. Mylan Company Details

Table 95. Mylan Business Overview

Table 96. Mylan Nocturia Product

Table 97. Mylan Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 98. Mylan Recent Development

Table 99. Novartis Company Details

Table 100. Novartis Business Overview

Table 101. Novartis Nocturia Product

Table 102. Novartis Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 103. Novartis Recent Development

Table 104. Johnson & Johnson Company Details

Table 105. Johnson & Johnson Business Overview

Table 106. Johnson & Johnson Nocturia Product

Table 107. Johnson & Johnson Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 108. Johnson & Johnson Recent Development

Table 109. Merck Company Details

Table 110. Merck Business Overview

Table 111. Merck Nocturia Product

Table 112. Merck Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 113. Merck Recent Development

Table 114. Astra Zeneca Company Details

Table 115. Astra Zeneca Business Overview

Table 116. Astra Zeneca Nocturia Product

Table 117. Astra Zeneca Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 118. Astra Zeneca Recent Development

Table 119. Bristol-Myers Squibb Company Details

Table 120. Bristol-Myers Squibb Business Overview

Table 121. Bristol-Myers Squibb Nocturia Product

Table 122. Bristol-Myers Squibb Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 123. Bristol-Myers Squibb Recent Development

Table 124. Hainan Zhonghe Pharmaceutical Company Details

Table 125. Hainan Zhonghe Pharmaceutical Business Overview

Table 126. Hainan Zhonghe Pharmaceutical Nocturia Product

Table 127. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 128. Hainan Zhonghe Pharmaceutical Recent Development

Table 129. Fosun Pharma Company Details

Table 130. Fosun Pharma Business Overview

Table 131. Fosun Pharma Nocturia Product

Table 132. Fosun Pharma Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 133. Fosun Pharma Recent Development

Table 134. Hybio Pharmaceutical Company Details

Table 135. Hybio Pharmaceutical Business Overview

Table 136. Hybio Pharmaceutical Nocturia Product

Table 137. Hybio Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 138. Hybio Pharmaceutical Recent Development

Table 139. Rechon Life Science AB Company Details

Table 140. Rechon Life Science AB Business Overview

Table 141. Rechon Life Science AB Nocturia Product

Table 142. Rechon Life Science AB Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 143. Rechon Life Science AB Recent Development

Table 144. Zhejiang Conba Pharmaceutical Company Details

Table 145. Zhejiang Conba Pharmaceutical Business Overview

Table 146. Zhejiang Conba Pharmaceutical Nocturia Product

Table 147. Zhejiang Conba Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 148. Zhejiang Conba Pharmaceutical Recent Development

Table 149. Chengdu Leer Pharmaceutical Company Details

Table 150. Chengdu Leer Pharmaceutical Business Overview

Table 151. Chengdu Leer Pharmaceutical Nocturia Product

Table 152. Chengdu Leer Pharmaceutical Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 153. Chengdu Leer Pharmaceutical Recent Development

Table 154. Nanjing Xingyin Pharmaceutical Group Company Details

Table 155. Nanjing Xingyin Pharmaceutical Group Business Overview

Table 156. Nanjing Xingyin Pharmaceutical Group Nocturia Product

Table 157. Nanjing Xingyin Pharmaceutical Group Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 158. Nanjing Xingyin Pharmaceutical Group Recent Development

Table 159. Sun Pharmaceutical Industries Ltd. Company Details

Table 160. Sun Pharmaceutical Industries Ltd. Business Overview

Table 161. Sun Pharmaceutical Industries Ltd. Nocturia Product

Table 162. Sun Pharmaceutical Industries Ltd. Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 163. Sun Pharmaceutical Industries Ltd. Recent Development

Table 164. APOTEX INC Company Details

Table 165. APOTEX INC Business Overview

Table 166. APOTEX INC Nocturia Product

Table 167. APOTEX INC Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 168. APOTEX INC Recent Development

Table 169. Sagent Pharmaceuticals Company Details

Table 170. Sagent Pharmaceuticals Business Overview

Table 171. Sagent Pharmaceuticals Nocturia Product

Table 172. Sagent Pharmaceuticals Revenue in Nocturia Business (2020-2025) & (US$ Million)

Table 173. Sagent Pharmaceuticals Recent Development

Table 174. Research Programs/Design for This Report

Table 175. Key Data Information from Secondary Sources

Table 176. Key Data Information from Primary Sources

Table 177. Authors List of This Report

List of Figures

Figure 1. Nocturia Picture

Figure 2. Global Nocturia Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nocturia Market Share by Type: 2024 VS 2031

Figure 4. Desmopressin Features

Figure 5. Anticholinergic Drugs Features

Figure 6. Alpha Blockers Features

Figure 7. Diuretics Features

Figure 8. Others Features

Figure 9. Global Nocturia Market Size by Sale Channels (2020-2031) & (US$ Million)

Figure 10. Global Nocturia Market Share by Sale Channels: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Nocturia Report Years Considered

Figure 15. Global Nocturia Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Nocturia Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Nocturia Market Share by Region: 2024 VS 2031

Figure 18. Global Nocturia Market Share by Players in 2024

Figure 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2024

Figure 21. North America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Nocturia Market Share by Country (2020-2031)

Figure 23. United States Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Nocturia Market Share by Country (2020-2031)

Figure 27. Germany Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Nocturia Market Share by Region (2020-2031)

Figure 35. China Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Nocturia Market Share by Country (2020-2031)

Figure 43. Mexico Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Nocturia Market Share by Country (2020-2031)

Figure 47. Turkey Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Nocturia Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Astellas Pharma Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 51. Allergan Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 52. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 53. Eli Lilly Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 55. Sanofi Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 56. Pfizer Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 57. Abbott Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 58. Teva Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 59. Mylan Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 60. Novartis Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 61. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 62. Merck Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 63. Astra Zeneca Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 65. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 66. Fosun Pharma Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 67. Hybio Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 68. Rechon Life Science AB Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 69. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 70. Chengdu Leer Pharmaceutical Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 71. Nanjing Xingyin Pharmaceutical Group Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 72. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 73. APOTEX INC Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 74. Sagent Pharmaceuticals Revenue Growth Rate in Nocturia Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global OAB Treatment Market Research Report 2025

Medicines for Urge Incontinence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nocturnal Polyuria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary Incontinence Market Research Report 2024

Sleep Wake Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adult Urinary Incontinence Treatment Device Market Research Report 2025

Global Adult Urinary Incontinence Implantable Device Market Research Report 2025

Global Circadian Rhythm Sleep Disorders Market Insights Forecast to 2030

Global Sleep Movement Disorder Drug Market Insights Forecast to 2030

Medicine for Stress Incontinence Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nocturia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Men s Urinary Incontinence Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hypersomnia Drug Market Insights Forecast to 2030

Global Implanted Urinary Incontinence Device Market Research Report 2025

Global Anticholinergic Drugs for OAB Treatment Market Research Report 2024

Global Urinary Incontinence Electrical Stimulation Device Market Research Report 2025

Non Surgical Urinary Incontinence Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Circadian Rhythm Sleep Treatment Market Research Report 2025

Global Incontinence Care and Management Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions